Understanding The Role of RANP1 in Cell Signaling and Development

Target Name: RANP1

NCBI ID: G221547

RANP1

Other Name(s): Ras-like | RAN pseudogene 1 | RAN, member RAS oncogene family pseudogene 1 | TC4

Understanding The Role of RANP1 in Cell Signaling and Development

Ras-like proteins, or RLPs, are a family of non-coding RNAs that play a crucial role in cell signaling and development. RLPs are characterized by their ability to self-assemble into distinct cellular structures, such as RNA granules and protein-protein interactions, which are critical for their function. One member of this family, RANP1, has been identified as a potential drug target and biomarker for several diseases.

The RANP1 gene is located on chromosome 18 and encodes a protein of approximately 200 amino acids. RANP1 is highly conserved across various species, and its sequence is highly similar to that of other RLPs, such as sonic hedgehog (SHH) and SNAF. RANP1 is expressed in various tissues and cells of the body, including fetal brain, pancreatic cancer, and breast cancer.

Functional studies have shown that RANP1 plays a critical role in cell signaling and development. RANP1 is involved in the regulation of cell adhesion, migration, and the formation of tissues such as the nervous system and pancreas. It is also involved in the regulation of cell survival and the establishment of normal cellular processes.

In addition to its role in cell signaling and development, RANP1 has also been shown to be a potential drug target. Several studies have shown that RANP1 can be targeted by small molecules, such as inhibitors of tyrosination and aggregation of RANP1, leading to the inhibition of cell signaling and the downregulation of RANP1-containing genes. This suggests that RANP1 may be a promising target for small molecule inhibitors in cancer treatment.

Furthermore, some studies have also shown that RANP1 may be used as a biomarker for several diseases, including pancreatic cancer, breast cancer, and neurodegenerative diseases. This is because RANP1 is expressed in these diseases and can be used as a protein biomarker to diagnose and monitor the progression of these diseases.

In conclusion, RANP1 is a member of the RAS-like family of non-coding RNAs that plays a critical role in cell signaling and development. Its function as a potential drug target and biomarker makes it an attractive target for small molecule inhibitors in cancer treatment. Further research is needed to fully understand the role of RANP1 in cell signaling and development, as well as its potential as a biomarker for disease.

Protein Name: RAN Pseudogene 1

The "RANP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RANP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets